Platform Radiooncology and Nuclear Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine of Vienna, Vienna, Austria.
ATRAB-Applied and Translational Radiobiology, Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria.
Strahlenther Onkol. 2021 Jun;197(6):537-546. doi: 10.1007/s00066-021-01751-y. Epub 2021 Mar 10.
In a previous study we have shown in a mouse model that administration of nuclear factor-kappa B (NF-κB) inhibitor thalidomide has promising therapeutic effects on early radiation cystitis (ERC) and late radiation sequelae (LRS) of the urinary bladder. The aim of this study was to evaluate in the same mice the effect of thalidomide on adherens junction (AJ) proteins in ERC and LRS.
Urothelial expressions of E‑cadherin and β‑catenin were assessed by immunohistochemistry in formalin-fixed paraffin-embedded (FFPE) bladder specimens over 360 days post single-dose irradiation on day 0. First, the effect of irradiation on AJ expression and then effects of thalidomide on irradiation-induced AJ alterations were assessed using three different treatment times.
Irradiation provoked a biphasic upregulation of E‑cadherin and β‑catenin in the early phase. After a mild decrease of E‑cadherin and a pronounced decrease of β‑catenin at the end of the early phase, both increased again in the late phase. Early administration of thalidomide (day 1-15) resulted in a steeper rise in the first days, an extended and increased expression at the end of the early phase and a higher expression of β‑catenin alone at the beginning of the late phase.
Upregulation of AJ proteins is an attempt to compensate irradiation-induced impairment of urothelial barrier function. Early administration of thalidomide improves these compensatory mechanisms by inhibiting NF-κB signaling and its interfering effects.
在之前的一项研究中,我们在小鼠模型中发现,给予核因子-κB(NF-κB)抑制剂沙利度胺对早期放射性膀胱炎(ERC)和膀胱晚期放射性后遗症(LRS)具有良好的治疗作用。本研究的目的是在同一批小鼠中评估沙利度胺对 ERC 和 LRS 黏着连接(AJ)蛋白的影响。
采用免疫组织化学方法检测 0 天单次照射后 360 天福尔马林固定石蜡包埋(FFPE)膀胱标本中 E-钙黏蛋白和β-连环蛋白的尿路上皮表达。首先评估照射对 AJ 表达的影响,然后评估沙利度胺对照射诱导的 AJ 改变的影响,使用三种不同的治疗时间。
照射在早期引起 E-钙黏蛋白和β-连环蛋白的双相上调。在早期阶段 E-钙黏蛋白和β-连环蛋白轻度减少后,在早期结束时明显减少,随后在晚期再次增加。早期给予沙利度胺(第 1-15 天)导致在最初几天急剧上升,早期结束时表达延长且增加,并在晚期开始时β-连环蛋白单独表达增加。
AJ 蛋白的上调是补偿照射诱导的尿路上皮屏障功能损伤的一种尝试。早期给予沙利度胺通过抑制 NF-κB 信号及其干扰作用,改善这些补偿机制。